Atractylenolide I
APC-319
Atractylenolide I
Cat. No.
APC-319
CAS No.
73069-13-3
MF
C15H18O2
MW
230.3022
Atractylenolide I is a sesquiterpene derived from the rhizome of Atractylodes macrocephala and acts as a TLR4-antagonizing agent.
Technical Service Need help? Our team of experienced experts is here for you with full support.
86-28-85159085
info@aktin.com
Technical Data
Description
Storage and Shipping
References
Product Name
CAS No.
73069-13-3
MF
C15H18O2
MW
230.3022
Specification
98%
Research Area
Neuroprotective, anti-allergic, anti-inflammatory
Description
Atractylenolide I is a sesquiterpene derived from the rhizome of Atractylodes macrocephala and acts as a TLR4-antagonizing agent. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Documents
Certificate of Analysis (COA), Specification Sheet, HPLC, 1HNMR, 13CNMR, IR, MS, Safety Data Sheet (SDS/MSDS) etc.
Storage and Shipping
Store under frozen or refrigerated conditions, keep away from strong light and heat
References
[1]. Atractylenolide I, et al. The JAK2/STAT3 pathway is involved in the anti-melanoma effects of atractylenolide I. Exp Dermatol. 2018 Feb;27(2):201-204.
[2]. Gao H, et al. Anti-depressant-like effect of atractylenolide I in a mouse model of depression induced by chronic unpredictable mild stress. Exp Ther Med. 2018 Feb;15(2):1574-1579.
[3]. Li W, et al. Atractylenolide I restores HO-1 expression and inhibits Ox-LDL-induced VSMCs proliferation, migration and inflammatory responses in vitro. Exp Cell Res. 2017 Apr 1;353(1):26-34.
[4]. Huang JM, et al. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. Sci Rep. 2014 Jan 23;4:3840.
[2]. Gao H, et al. Anti-depressant-like effect of atractylenolide I in a mouse model of depression induced by chronic unpredictable mild stress. Exp Ther Med. 2018 Feb;15(2):1574-1579.
[3]. Li W, et al. Atractylenolide I restores HO-1 expression and inhibits Ox-LDL-induced VSMCs proliferation, migration and inflammatory responses in vitro. Exp Cell Res. 2017 Apr 1;353(1):26-34.
[4]. Huang JM, et al. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. Sci Rep. 2014 Jan 23;4:3840.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
APC-1828
Eritadenine
CAS No.: 23918-98-1
MF: C9H11N5O4
APC-1827
Isobutyrylshikonin
CAS No.:52438-12-7
MF:C20H22O6
APC-1823
SO1861 (C28 sugar-chain positional isomer)
CAS No.:N/A
MF:C83H129O46
APC-1822
Bromocriptine mesylate
CAS No.:22260-51-1
MF:C32H40BrN5O5.CH4O3S
APC-1821
Cephaeline hydrochloride
CAS No.:3738-70-3
MF:C28H38N2O4.ClH
APC-1820
8-Feruloylharpagide
CAS No.:221003-20-9
MF:C25H32O13
APC-1819
6''-O-(p-coumaroyl)procumbide
CAS No.:87686-76-8
MF:C24H28O12
APC-1818
6′′-O-(p-Coumaroyl)harpagide
CAS No.:133561-42-9
MF:C24H30O12
APC-1817
Falcarinol
CAS No.:21852-80-2
MF:C17H24O
APC-1816
Dehydrotomatine
CAS No.:157604-98-3
MF:C50H81NO21
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
